Wei Jiang Goh

Dr. Wei Jiang Goh

Craft Health Pte Ltd, Singapore, Central Singapore, Singapore
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WGWei Jiang Goh
Wei Jiang Goh
SZShui Zou
Shui Zou
WOWei Yi Ong
Wei Yi Ong
FTFederico Torta
Federico Torta
AAAlvarez Fernandez Alexandra
Alvarez Fernandez Alexandra
GPGiorgia Pastorin
Giorgia Pastorin
Cell Derived Nanovesicles (CDNs) have been developed from the rapidly expanding field of exosomes, representing a class of bioinspired Drug Delivery Systems (DDS). However, translation to clinical applications is limited by the low yield and multi-step approach in isolating naturally secreted exosomes. Here, we show the first demonstration of a simple and rapid production method of CDNs using spin cups via a cell shearing approach, which offers clear advantages in terms of yield and cost-effectiveness over both traditional exosomes isolation, and also existing CDNs fabrication techniques. The CDNs obtained were of a higher protein yield and showed similarities in terms of physical characterization, protein and lipid analysis to both exosomes and CDNs previously reported in the literature. In addition, we investigated the mechanisms of cellular uptake of CDNs in vitro and their biodistribution in an in vivo mouse tumour model. Colocalization of the CDNs at the tumour site in a cancer mouse model was demonstrated, highlighting the potential for CDNs as anti-cancer strategy. Taken together, the results suggest that CDNs could provide a cost-effective alternative to exosomes as an ideal drug nanocarrier.

1 April 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
WGWei Jiang Goh
Wei Jiang Goh
CLChoon Keong Lee
Choon Keong Lee
SZShui Zou
Shui Zou
EWEsther Woon
Esther Woon
BCBertrand Czarny
Bertrand Czarny
GPGiorgia Pastorin
Giorgia Pastorin
Cell-derived nanovesicles (CDNs) are an emerging class of biological drug delivery systems (DDS) that retain the characteristics of the cells they were derived from, without the need for further surface functionalization. CDNs are also biocompatible, being derived from natural sources and also take advantage of the enhanced permeability and retention effect due to their nanodimensions. Furthermore, CDNs derived from monocytes were shown to have an in vivo targeting effect, accumulating at the tumor site in a previous study conducted in a mouse tumor model. Here, we report a systematic approach pertaining to various loading methods of the chemotherapeutic drug doxorubicin into our CDNs and examine the differential cellular uptake of drug-loaded CDNs in cancerous (HeLa) and healthy (HEK293) cell lines. Lastly, we proved that the addition of doxorubicin-loaded CDNs to the HeLa and HEK293 co-cultures showed a clear discrimination toward cancer cells at the cellular level. Our results further reinforce the intriguing potential of CDNs as an alternative targeted strategy for anticancer therapy.

28 November 2012 in Langmuir
Verified
Journal Article
Closed access
WGWei Jiang Goh
Wei Jiang Goh
VMVenkata S. Makam
Venkata S. Makam
JHJun Hu
Jun Hu
LKLifeng Kang
Lifeng Kang
MZMinrui Zheng
Minrui Zheng
GPGiorgia Pastorin
Giorgia Pastorin

23 April 2012 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
JKJaspreet Singh Kochhar
Jaspreet Singh Kochhar
WGWei Jiang Goh
Wei Jiang Goh
SCSui Yung Chan
Sui Yung Chan
LKLifeng Kang
Lifeng Kang
The outermost layer of skin, stratum corneum, being lipophilic limits the passive transport of hydrophilic and large molecular weight drugs. Microfabrication technology has been adapted to fabricate micron scale needles, which are minimally invasive, yet able to deliver the drugs across this barrier layer. In this study, we fabricated microneedles from a biocompatible polymer, namely, poly (ethylene glycol) diacrylate. A simple lithographical approach was developed for microneedle array fabrication. Several factors including polymerization time, ultraviolet light intensity and distance from light source were studied for their effects on microneedle formation. The microneedle length and tip diameter can be controlled by varying these factors. The microneedles were shown to be able to penetrate cadaver pig skin. Model drug rhodamine B was encapsulated in the range of 50 µg to 450 µg per microneedle array. The fabricated microneedles containing rhodamine B increased the permeability by four times than the control. Altogether, we demonstrated that the microneedle arrays can be fabricated through a simple single-step process and needles were mechanically strong to penetrate skin, increasing the permeability of encapsulated drug through skin.

8 December 2017 in Biomacromolecules
Verified
Journal Article
Closed access
WGWei Jiang Goh
Wei Jiang Goh
SZShui Zou
Shui Zou
CLChoon Keong Lee
Choon Keong Lee
YOYi-Hsuan Ou
Yi-Hsuan Ou
Jiong-Wei WangJiong-Wei Wang
Jiong-Wei Wang
GPGiorgia Pastorin
Giorgia Pastorin

21 July 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
OGOdelia Goh
Odelia Goh
WGWei Jiang Goh
Wei Jiang Goh
SLSeng Han Lim
Seng Han Lim
GHGrace S. Hoo
Grace S. Hoo
RLRaymond Liew
Raymond Liew
TNtat ming ng
tat ming ng
An inaugural study was performed to understand the perceptions of healthcare professionals toward the potential benefits of 3D printing in Singapore. This study sought to increase awareness of 3D printing applications for viable clinical applications and to elucidate the current gaps in therapy where 3D printing could play a role. A common example would be the use of 3D printing to manufacture polypills, thereby reducing the daily pill burden of patients and possibly improving medication adherence. A qualitative descriptive survey with a single-centered cross-sectional design was performed at Tan Tock Seng Hospital, a tertiary referral hospital with 1700 beds. This study had a total of 55 respondents comprising doctors and pharmacists. Most of the respondents viewed the 3D printing of oral dosage forms favorably and agreed about the potential advantages this technology could offer. More than 60% of the respondents were also willing to prescribe 3D printed tablets to patients. Respondents’ concerns were grouped into three main categories: formulation considerations, manufacturing processes, and administrative issues. Viewed in its entirety, this study provides a valuable starting point for understanding the perceptions of healthcare professionals in adopting 3D printing technology.